Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06135727 · ClinicalTrials.gov registry record
Screening Protocol
A clinical trial, sponsored by Topcon Corporation.
- Terminated
- Registry status
- 26
- Enrollment target
NCT06135727: Clinical Trial study, sponsored by Topcon Corporation.
NCT06135727 is a clinical trial that was terminated before completion, run by Topcon Corporation. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06135727 was terminated before completion, sponsored by Topcon Corporation.
- TERMINATED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The objective of this study is to collect data for the development and validation a screening process using aggregate data. In this study, data collection will encompass both retrospective and prospective approaches across multiple sites in the United States.
Interventions
- DEVICE Maestro2 OCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-11-07 |
| Est. Completion | 2024-08-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06135727
The ClinicalTrials.gov registry entry for NCT06135727 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Topcon Corporation, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Maestro2 OCT is the first listed.
NCT06135727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06135727 about?
NCT06135727 is a clinical study titled "Screening Protocol". The objective of this study is to collect data for the development and validation a screening process using aggregate data. In this study, data collection will encompass both retrospective and prospective approaches across multiple sites in the United States.
What is the current status of trial NCT06135727?
This trial is currently terminated. The enrollment target is 26 participants. The study started on 2023-11-07. Estimated completion is 2024-08-02.
What interventions are being tested in trial NCT06135727?
The interventions under investigation include: Maestro2 OCT (DEVICE).
Who is sponsoring clinical trial NCT06135727?
This trial is sponsored by Topcon Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.